Sorrento Therapeutics Inc (SRNE): The August Corporate Presentation does s...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	57
Posts	5700
Boards Moderated	0
Alias Born	12/13/2004

dia76ca

Re: None

Friday, 08/26/2022 10:40:21 AM

Friday, August 26, 2022 10:40:21 AM

The August Corporate Presentation does seem to highlight ABIVERTINIB, Mpro, Virex and SEMDEXA.
But we know that beside these top 4 multibillion $ programs they are advancing many other high potential programs. e.g. PD-L1, ADNAB, DAR-T, RTX, SOFUSA!
My assumption is that the top 4 programs are closest to market.
https://investors.sorrentotherapeutics.com/static-files/ded13448-aa64-4405-a2d9-de644cfe9dfc

"The refusal of the real is the number one dogma of our time" Rene Girard

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent SRNE News

Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 09:31:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:15:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 01:51:06 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 09:25:07 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/07/2023 08:15:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 10:01:54 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 10:26:26 AM